CClinicalTrials.gg
Not yet recruitingNCT07179185PRECISE-ECGUpdated Sep 22, 2025

Evaluation of Clinical Intelligence Support to Reduce Errors in Normal ECGs

An interventional study of AI-Assisted ECG Interpretation (AI-ECG) and Specialist ECG Interpretation Without AI in Electrocardiogram and Cardiovascular Abnormalities, sponsored by Federal University of Minas Gerais. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-22.

Sponsored by Federal University of Minas Gerais · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
710
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will evaluate the performance of specialist physicians in interpreting normal electrocardiograms (ECGs) with and without the assistance of an artificial intelligence (AI) neural network. The primary aim is to determine whether AI support affects the rate of false-positive interpretations of normal tracings. Secondary aims include evaluating the time required for interpretation, the sensitivity for detecting abnormalities, and the effect on false positives in ECGs with major abnormalities according to the Minnesota Code system. All ECGs in the sample will be reviewed by a panel of three specialists, to determine the reference classification.

02

Conditions studied

  • Electrocardiogram
  • Cardiovascular Abnormalities

Keywords

  • artificial intelligence
  • electrocardiography
  • diagnostic methods
  • telemedicine
  • normal electrocardiogram
03

In context

Cardiovascular Abnormalities

59 studies on the registry are indexed under Cardiovascular Abnormalities; 14 are open to participants now.

This study's planned enrollment of 710 is above the median of 60 across 33 interventional studies indexed under Cardiovascular Abnormalities.

Browse Cardiovascular Abnormalities studies →

Lead sponsor

Federal University of Minas Gerais is the lead sponsor of 150 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ECGs performed routinely by the Rede de Telemedicina de Minas Gerais (RTMG)

Exclusion criteria

Exclusion Criteria:

  • ECGs from patients younger than 18 years
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
710 participants (estimated)

Study arms

  • Active comparator
    Control - Specialist Interpretation Without AI

    Specialist physicians interpret normal ECGs without the assistance of the AI-ECG tool. ECGs are routine tracings performed by the Rede de Telemedicina de Minas Gerais (RTMG). Final classification for study endpoints will be based on a panel review by three specialists.

    Diagnostic Test: Specialist ECG Interpretation Without AI

  • Experimental
    Specialist interpretation with AI assistance

    Specialist physicians interpret ECGs using the AI-ECG tool, which provides automated classification support indicating whether the ECG is normal or not. ECGs are routine tracings performed by RTMG. Final classification for study endpoints will be based on a panel review by three specialists.

    Diagnostic Test: AI-Assisted ECG Interpretation (AI-ECG)

Interventions

  • Diagnostic testAI-Assisted ECG Interpretation (AI-ECG)

    Neural network-based AI software that analyzes ECG tracings and provides a classification as normal suggestion to the interpreting specialist.

  • Diagnostic testSpecialist ECG Interpretation Without AI

    Manual interpretation of ECGs by specialists without AI support, following standard diagnostic procedures

06

What researchers measure

Primary outcomes

  1. Precision (Positive Predictive Value) for detection of normal ECG tracings

    Precision (Positive Predictive Value) of detecting normal ECG by the physician or physician+model compared against the reference standard defined by a panel of three specialists. Precision (Positive Predictive Value) is defined by the number of true positive normal cases divided by all positive predictions.

    Time frame: One week

Secondary outcomes

  1. Sensitivity, Specificity, Negative Predictive Value, and F1 score for detection of normal ECG tracings

    Accuracy evaluated by Sensitivity, Specificity, Negative Predictive Value, and F1 score of normal ECGs correctly identified by the physician or physician+model, in relation to a reference standard defined by a panel of three specialists.

    Time frame: One week

  2. ECGs with major abnormalities incorrectly classified as normal

    Ratio of ECGs with major abnormalities according to the Minnesota Code system among those incorrectly classified as normal by the physician or physician+model, in relation to a reference standard defined by a panel of three specialists.

    Time frame: One week

  3. Time of analysis for normal cases (seconds per case)

    Time required by the physician, or physician+model, to interpret normal ECGs, measured in seconds per case; the reference standard of normal cases defined by a panel of three specialists.

    Time frame: One week

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Oliveira CRA, Paixao GMM, Tostes VC, Gomes PR, Mendes MS, Paixao MC, Marcolino MS, Ribeiro ALP. Upscaling a regional telecardiology service to a nationwide coverage and beyond: the experience of the Telehealth Network of Minas Gerais. BMJ Glob Health. 2025 Jan 19;10(1):e016692. doi: 10.1136/bmjgh-2024-016692. PubMed 39828428 ↗
  • Ribeiro ALP, Paixao GMM, Gomes PR, Ribeiro MH, Ribeiro AH, Canazart JA, Oliveira DM, Ferreira MP, Lima EM, Moraes JL, Castro N, Ribeiro LB, Macfarlane PW. Tele-electrocardiography and bigdata: The CODE (Clinical Outcomes in Digital Electrocardiography) study. J Electrocardiol. 2019 Nov-Dec;57S:S75-S78. doi: 10.1016/j.jelectrocard.2019.09.008. Epub 2019 Sep 7. PubMed 31526573 ↗
  • Ribeiro AH, Ribeiro MH, Paixao GMM, Oliveira DM, Gomes PR, Canazart JA, Ferreira MPS, Andersson CR, Macfarlane PW, Meira W Jr, Schon TB, Ribeiro ALP. Automatic diagnosis of the 12-lead ECG using a deep neural network. Nat Commun. 2020 Apr 9;11(1):1760. doi: 10.1038/s41467-020-15432-4. PubMed 32273514 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07179185
Lead sponsor
Federal University of Minas Gerais
Collaborators
Uppsala University
Responsible party
Antonio Luiz Pinho Ribeiro (Full Professor, Internal Medicine Department, School of Medicine, Federal University of Minas Gerais) — Principal investigator
First posted
Sep 17, 2025
Start date
Oct 1, 2025 (estimated)
Primary completion
Oct 5, 2025 (estimated)
Completion
Nov 2025 (estimated)
Last update
Sep 22, 2025

Study contacts

Antonio Luiz P. Ribeiro, MD, PhD
Contact
alpr@ufmg.br
55(31)3307-9201
Gabriela Miana M. Paixão, MD, PhD
Contact
gabimiana@gmail.com
55(31) 3307-9201

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion